FOLLICUM
Follicum's research and development focuses on stimulating hair growth and diabetes. In connection with research on atherosclerosis, the founders of Follicum discovered that a modified variant of the body protein osteopontin increased hair growth in mice. The company's research is based on the body's own proteins from which we develop drugs. The most advanced peptide , FOL-005, affects the regulation of hair follicle activity.
FOLLICUM
Industry:
Biotechnology
Founded:
2004-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.follicum.se
Total Employee:
51+
Status:
Active
Contact:
+46 (0) 46 19 21 97
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Apache
Current Employees Featured
Official Site Inspections
http://www.follicum.se
- Host name: website-proxy.ilait.se
- IP address: 185.15.121.100
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Follicum"
Follicum - Crunchbase Company Profile & Funding
Follicum is a organization focuses on research and development of stimulating hair growth and diabetes. Lund, Skane Lan, Sweden; 51-100; Private; follicum.se/ 928,231; Highlights. Employee Profiles 1. Similar Companies 2. Recent News …See details»
Follicum - Crunchbase Company Profile & Funding
Follicum is a biotech company that develops dermacosmetic products for hair growth stimulation. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. …See details»
Follicum - LinkedIn
Lund, Skåne County 223 63, SE Get directions Similar pages Emmace Consulting AB Pharmaceutical Manufacturing ... Follicum is a subsidary of Coegin Pharma, a Nordic biotech hub & spoke company ...See details»
Follicum Company Profile 2024: Valuation, Investors, Acquisition ...
Follicum has raised $1.16M. Who are Follicum’s investors? Almi Invest , Lund University Bioscience , Sunstone Life Science Ventures , Swedish Growth Fund , and Vinnova have …See details»
Follicum Company Profile - Office Locations, Competitors ... - Craft
Follicum is a company focused on the stimulation of hair growth and diabetes. It develops FOL-005, a drug candidate that is based on the human protein ostepontin and designed to …See details»
Follicum - Sunstone
Follicum AB (Lund, Sweden) is an early-stage biopharmaceutical company focusing on developing novel therapeutics for the management of hair growth. Unwanted hair loss and …See details»
Follicum appoints new CEO and establishes new role as
"As Follicum's projects advances, new demands are placed on our organization. I am pleased with the Board's decision to expand the management team and recruit a new CEO to take the …See details»
Coegin Pharma fuses with Swedish biotech Follicum - BioStock
Sep 23, 2021 Soon after receiving the green light from the Danish Medicines Agency for initiating the phase I/II COAK study in actinic keratosis, Nordic biotech Coegin Pharma reveals …See details»
Follicum's new CEO on the next steps in the company's …
Lund-based Follicum develops drug candidates based on tissue repair peptides. The portfolio currently consists of two main projects where the candidate FOL-005 for the treatment of hair …See details»
New data strengthens Follicum’s diabetes project - BioStock
Mar 30, 2021 BioStock has contacted Follicum’s CEO Jan Alenfall to learn more about what this means for the project. Lund-based Follicum develops new peptide drugs in the areas of hair …See details»
Follicums prospekt - Follicum
Follicums prospekt (finns även under Rapporter) As part of Coegin Pharma AB’s hub & spoke “portfolio” business model, with clear benefits to investors, Coegin Pharma AB has established …See details»
Follicum Shares Results From Phase 2a Trial Of Topical FOL-005
May 6, 2021 Here’s a quote from Follicum’s new CEO Kim Arvid Nielsen in their latest press release, “Compared to the results achieved in previous preclinical and clinical studies of FOL …See details»
Follicum watches closely as Allergan deal shakes up hair ... - BioStock
Jul 6, 2021 Follicum is watching closely. Overall, this is welcome news for Follicum, a Swedish biotech company currently going through phase II trials with their peptide, FOL-005, a drug …See details»
Follicum, a Swedish biotech company born to find a treatment for …
Feb 27, 2019 Follicum, a peptide-focused virtual biotech company, was founded in 2011 out of a small research group at Lund University in Sweden. ... Much of the cost is due to serious …See details»
FOL-005 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 The trial was a multicentre, randomised, double-blind, placebo controlled phase 2 trial. 60 healthy bald male subjects diagnosed with alopecia, who are between 18 and 55 …See details»
First patient treated in Follicum’s Phase IIa study of FOL-005 for ...
Mar 8, 2018 Follicum AB have announced that the firstpatient has been treated in the Phase IIa clinical trial in Germany with its lead candidate FOL-005 on 60 patients with hair loss. The …See details»
Follicum takes a step closer to phase III entering 2021
BioStock spoke with Follicum’s CEO Jan Alenfall to get his impressions on the company’s highlights for 2020 and what to expect in 2021. Lund-based Follicum , which develops …See details»
New study results from Follicum - NLS - Nordic Life Science
Jul 1, 2021 Follicum reports revised data from a Phase IIa study of the tissue repairing peptide FOL-005 for the treatment of hair loss (alopecia). The revised data are based on an …See details»
Follicum’s CEO comments on directed share issue of SEK 37 million
Jul 3, 2021 Follicum, who´s Q3 report is expected on November 19, reported a cash balance of SEK 22.2 million at the half year mark and a burn rate of SEK 7.1 million during the second …See details»
Follicum finalises patient recruitment in hair growth study
Jul 3, 2021 Follicum’s FOL-005 is a compound in clinical development that has the potential not only to compete against current hair-loss medications in terms of efficacy, but it could …See details»